Logo

thyroid cancer

OncoDNA, Eli Lilly Partner on Thyroid Cancer Biomarker Testing

The companies are working together to offer next-generation sequencing-based molecular testing on thyroid cancer biopsies to clinicians in Italy.

Thermo Fisher Gets FDA OK for CDx Test to Guide Use of Lilly Drug in Lung, Thyroid Cancers

The NGS-based Oncomine Dx Target Test will help ID patients with advanced RET-driven lung and thyroid cancers who may be eligible for treatment with Eli Lilly's Retevmo.

Genetron Health Adds New Assays to Pipeline While Anticipating MRD Launch, Liver Cancer Kit Trials
Premium

As it eyes new targets, the firm is poised to launch its personalized solid tumor MRD assay this year and is progressing toward approval for a liver cancer early detection IVD.

Interpace Biosciences Says CMS to Cover Thyroid Tests, Reversing Earlier Decision

CMS previously said it would no longer reimburse for the ThyGeNext and ThyraMir tests when the tests are billed together.

CMS No Longer Reimbursing Interpace Bio Thyroid Tests; Firm's Rights Offering Terminated

CMS has issued a new billing policy and will no longer reimburse for the use of Interpace's ThyGeNext and ThyraMir thyroid cancer tests under certain conditions.

Dec 7, 2021

Pan-Cancer Analysis Reveals Unique Features in Tumors From Younger People

Jul 29, 2021

Veracyte Q2 Revenues More Than Double on Test Volume Spike

Apr 22, 2021

Genomic Effects of Radiation From Chernobyl Nuclear Disaster Examined in New Studies

Dec 22, 2020

Bayer, Veracyte to Identify Therapy-Resistant Thyroid Cancer Patients

Dec 10, 2020

Tempus Raises $200M in Series G2, Inks Oncology Testing Collaboration With Bayer

Nov 3, 2020

Biocartis Collaborating With GeneproDx, Endpoint Health on Tests for Idylla Platform

Jun 9, 2020

NeoGenomics, Lilly Oncology Partner for Thyroid Cancer Testing Program

Jun 5, 2020

Secondary Tumor Risk in Pediatric Cancer Survivors Linked to Germline Variants, Treatment Type

Apr 21, 2020

ArcherDx, Premier Collaborate to Evaluate Genomic Sequencing Assay for Cancers

Jan 31, 2020

Chilean Startup GeneproDx Developing Molecular Test to Determine Thyroid Cancer Risk
Premium

Dec 20, 2019

Interpace Biosciences Expanding Beyond Dx, Cancer With Acquisition, Name Change
Premium

Dec 19, 2019

Guardant Health Liquid Biopsy Test Gets Expanded Medicare Coverage for Solid Tumors

Dec 2, 2019

Genetron Health Gets China NMPA Approval for Clinical NGS System, Files for IPO

Nov 13, 2019

Interpace Diagnostics Reports 33 Percent Q3 Revenue Growth; Changes Name to Interpace Biosciences

Nov 5, 2019

Sonic Healthcare Expands Deal for UPMC's ThyroSeq Thyroid Cancer Test

Sep 30, 2019

Interpace Diagnostics Signs Thyroid Cancer Test Coverage Deals With Three BCBS Plans

Sep 9, 2019

Thermo Fisher Scientific, Eli Lilly to Develop CDx for RET Inhibitor

Aug 13, 2019

Interpace Diagnostics Q2 Revenues Climb 14 Percent

Jul 31, 2019

Interpace Diagnostics Thyroid Tests Covered In-Network by BCBS of Michigan

Jul 29, 2019

Interpace Diagnostics Thyroid Assays Covered In-Network by Blue Shield of California

Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.